The effect of sulthiame on potential biomarkers in moderate to severe obstructive sleep apnoea
Background Obstructive sleep apnoea (OSA) is a common disease with breathing disturbances during sleep. Sulthiame (STM), a carbonic anhydrase (CA) inhibitor, was recently shown to reduce OSA in a significant proportion of patients. CA activity and hypoxia-inducible factor (HIF)-1α are two potential...
Saved in:
Main Authors: | Erik Hoff, Saliha Musovic, Ali M. Komai, Ding Zou, Christian Strassberger, Kaj Stenlöf, Ludger Grote, Jan Hedner |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2024-12-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/10/6/00342-2024.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nocturnal sweating—a common symptom of obstructive sleep apnoea: the Icelandic sleep apnoea cohort
by: Thorarinn Gislason, et al.
Published: (2013-05-01) -
Emotions in the course of obstructive sleep apnoea
vs. nurses’ support
by: Aneta Milaniak, et al.
Published: (2025-01-01) -
Sleep fragmentation and hypoxaemia as key indicators of cognitive impairment in patients with obstructive sleep apnoea
by: Thomas Georgeson, et al.
Published: (2025-01-01) -
The Treg/Th17 Imbalance in Patients with Obstructive Sleep Apnoea Syndrome
by: Jin Ye, et al.
Published: (2012-01-01) -
Driving restrictions in patients with obstructive sleep apnoea: who, how and are they effective?
by: Walter T. McNicholas
Published: (2024-12-01)